Veterinary medicines European public assessment report (EPAR): Syvazul BTV 3, bluetongue virus vaccine (inactivated), Status: Authorised
Veterinary medicines European public assessment report (EPAR): Daxocox, enflicoxib, Status: Authorised
Veterinary medicines European public assessment report (EPAR): Nobivac LeuFel, feline leukaemia vaccine (inactivated), Status: Authorised
Veterinary medicines European public assessment report (EPAR): Nobivac Myxo-RHD Plus, myxomatosis and rabbit haemorrhagic viral disease vaccine (live recombinant), Status: Authorised
Veterinary medicines European public assessment report (EPAR): Leucogen, feline leukaemia vaccine (inactivated), Status: Authorised
Decision of the Executive Director on rules governing the secondment of national experts to the EMA (from 1 October 2025)
Veterinary medicines European public assessment report (EPAR): Eravac, rabbit haemorrhagic disease vaccine (inactivated), Status: Authorised
Veterinary medicines European public assessment report (EPAR): Startvac, adjuvanted inactivated vaccine for cattle against Staphylococcus aureus, coliforms and coagulase-negative staphylococci, Status: Authorised
Veterinary medicines European public assessment report (EPAR): Suvaxyn CSF Marker, classical swine fever vaccine (live recombinant), Status: Authorised
Veterinary medicines European public assessment report (EPAR): NexGard, afoxolaner, Status: Authorised